CHMP recommends CAR T for ALL, DLBCLJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends CAR T for DLBCL, PMBCLJuly 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
CHMP backs expanded approval of tocilizumabJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
FDA lifts hold on trial of MYC inhibitorJuly 2, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Doc reports favorable results from trial on holdJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Group updates guidelines on CLLJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CPI-613 receives orphan designation for BLJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Many CCSs not concerned about future healthJune 28, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsRelated Issues
Company stops development of eryaspase in ALLJune 27, 2018Leukemia, Myelodysplasia, TransplantationALL
Ibrutinib sNDA receives priority reviewJune 26, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
